LUBIPROSTONE: A NOVEL DRUG TO TREAT CONSTIPATION

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 2

Abstract

Lubiprostone, a bicyclic fatty acid, is a novel drug of new class of agents called prostones. It is approved by US FDA for the treatment of chronic constipation and constipation associated irritable bowel syndrome (IBS-C). It activates specific chloride channels in the gastrointestinal tract to stimulate intestinal fluid secretion, increase gastrointestinal transit and improve symptoms of constipation. Lubiprostone is well tolerated in majority of the patients with nausea being the most common adverse effect. Lubiprostone represents a new approach of treatment in cases of resistant or intolerable cases of chronic constipation with proven efficacy and safety.

Authors and Affiliations

Kamlesh Garg*| Assistant Professor, Department of Pharmacology, VMMC and Safdarjung Hospital, New Delhi, Surinder Kumar| Medical officer, Department of Anesthesia, VMMC and Safdarjung Hospital, New Delhi, Ruchika Nanda| Assistant Professor, Department of Pharmacology, Dr HSJ Institute of Dental Sciences, Panjab University, Chandigarh, Suraj B| Junior Resident, Department of Pharmacology, VMMC and Safdarjung Hospital, New Delhi

Keywords

Related Articles

PREPARATION AND EVALUATION OF NANOSUSPENSION OF POORLY SOLUBLE DRUG ALBENDAZOLE

The aim of the present work was to enhance solubility of albendazole a class II drug by nanosuspension technology. Nanosuspensions are prepared by using wet mill, high pressure homogenizer, emulsionā€solvent diffusion, me...

A REVIEW ON BILAYER TABLETS

Over the past 30 years stated that the expense and complications involved in marketing new drug entities have increased, with concomitant recognition of therapeutic advantages of controlled drug delivery, greater attenti...

Formulation and evaluation of tramadol and diclofenac sodium multimodal sustain release tablet dosage form

Pain is treated using the unimodal pain management which are based on either central analgesic drug mechanism or other drug like nsaid. These drugs control the pain by central nervous system or peripheral nervous system....

A review on recent advances of oral mouth dissolving tablet

Mouth dissolving tablets are disintegrating and dissolve rapidly in mouth cavity without need of water. Many tablets are design to dissolve in mouth fast in few second and other true fast dissolving tablets. Oral mouth d...

A suspected case of diphtheria, pertussis and tetanus vaccine (DPT) induced seizure in a paediatric patient

A 4-month old male child developed convulsions possibly following diptheria, pertusis (whooping cough), and tetanus (DPT) vaccine used for routine immunization. A diagnosis of vaccine induced seizures was made after ruli...

Download PDF file
  • EP ID EP1345
  • DOI -
  • Views 695
  • Downloads 53

How To Cite

Kamlesh Garg*, Surinder Kumar, Ruchika Nanda, Suraj B (2013). LUBIPROSTONE: A NOVEL DRUG TO TREAT CONSTIPATION. Journal of Drug Discovery and Therapeutics, 1(2), 1-4. https://europub.co.uk/articles/-A-1345